Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib Capsule
NCT04768985
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalence
Interventions
DRUG:
Treatment A: Acalabrutinib tablet
DRUG:
Treatment B: Acalabrutinib capsule
Sponsor
AstraZeneca